Premium
Cross‐border reprogenetic services
Author(s) -
Couture V.,
Drouin R.,
Tan S.L.,
Moutquin J.M.,
Bouffard C.
Publication year - 2015
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12418
Subject(s) - scope (computer science) , phenomenon , service (business) , economic justice , political science , corporate governance , public relations , narrative , business , medicine , law , computer science , marketing , programming language , linguistics , philosophy , physics , finance , quantum mechanics
The purpose of this review is to synthesize the current knowledge on the international movement of patients and biopsied embryo cells for pre‐implantation genetic diagnosis and its different applications. Thus far, few attempts have been made to identify the specific nature of this phenomenon called ‘cross‐border reprogenetic services’. There is scattered evidence, both empirical and speculative, suggesting that these services raise major issues in terms of service provision, risks for patients and the children‐to‐come, the legal liabilities of physicians, as well as social justice. To compile this evidence, this review uses the narrative overview protocol combined with thematic analysis. Five major themes have emerged from the literature at the conjunction of cross‐border treatments and reprogenetics: ‘scope’, ‘scale’, ‘motivations’, ‘concerns’, and ‘governance’. Similar themes have already been observed in the case of other medical tourism activities, but this review highlights their singularity with reprogenetic services. It emphasizes the diagnostic and autologous feature of reprogenetics, the constant risk of misdiagnosis, the restriction on certain tests for medically controversial conditions, and the uncertain accessibility of genetic counseling in cross‐border settings.